ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

YGEN Yourgene Health Plc

0.515
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Yourgene Health Plc LSE:YGEN London Ordinary Share GB00BN31ZD89 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.515 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Yourgene Health Share Discussion Threads

Showing 5251 to 5273 of 5450 messages
Chat Pages: 218  217  216  215  214  213  212  211  210  209  208  207  Older
DateSubjectAuthorDiscuss
17/3/2023
08:03
Some good news at last! About 6 years too late. At least one more to go hopefully!
birdie12
14/3/2023
14:49
Just mainly small pi trades bar one sizeable one. People are fed up with the radio silence. Needs some good news pdq.
birdie12
14/3/2023
14:35
Looks like it’s gonna go through the placing price at this rate. And I don’t think that’s a tree shake.
major courtenay
13/3/2023
14:26
basically a 6.6M euro framework contract .
birdie12
13/3/2023
14:21
Oh! I thought it had translated. Is there not a translation button? Top right hand corner for translations.
birdie12
13/3/2023
14:12
My French isn’t up to par. Care to elaborate birdie?
major courtenay
13/3/2023
13:50
LOL! agreed. There should be plenty of news coming along. This is interesting too...
birdie12
13/3/2023
12:53
You could well be right birdie. Time will tell, but I did do a modest top up earlier. When you can buy well under the mid and so close to the placing price, it seems rude not to.
major courtenay
13/3/2023
12:47
Why would they shuffle off now at this price? They will expect to multi bag, same as me. Just fed up short term pi with another rainbow to chase.
birdie12
13/3/2023
11:26
Buying under the mid price. Wouldn’t be surprised if the price comes down. I wonder if some of the placees are shuffling off. Unless anyone has any alternative thoughts?
major courtenay
13/3/2023
07:43
Looks like management were on the case anyway. Still a relief though.
birdie12
12/3/2023
22:37
TW having his say,,anyone subscribed?
birdie12
12/3/2023
21:39
ADVFN Advised through help thread that fundamental data wrong.

Not nearly as tasty a nibble now -

pugugly
12/3/2023
21:03
PUG, they are wrong! Nearer £10M
birdie12
12/3/2023
21:00
The only debt is what is owed to SVB, and the IP is worth millions.
birdie12
12/3/2023
20:58
birdie12. I was going by the figure from the Advfn quote and the financials.
pugugly
12/3/2023
20:53
PUG, you on the wrong BB? Mcap £2.3M er don't think so!
birdie12
12/3/2023
20:51
not much point calling in the loans early as they can't pay it because they have no cash to pay it remember!
birdie12
12/3/2023
20:47
Deleted as figures and value taken from Advfn fundamentals are WRONG!!
See correction post 3169 below

pugugly
12/3/2023
20:43
how do you know they haven't drawn down the lot?
birdie12
12/3/2023
20:31
an offer has already been made for SVB UK. A consortium led by the Bank of London.
birdie12
12/3/2023
19:47
pug - I think the only insuperable problem would be if svb wanted to call in the loans to maintain its own balance sheet. I think we really just have to wait and see what the Chancellor proposes as a help scheme.
supernumerary
12/3/2023
19:39
YGEN and SVP@yourgene owe,rather than have trapped deposits.However, if they need the outstanding 0.9M then they'll need supportAt the beginning of 2022, AIM-quoted diagnostics firm Yourgene Healthcare entered into a three-year, £5m loan facility with Silicon Valley Bank. There was £4.1m drawn down by September 2022 when net debt was £1.7m.A placing and retail offer raised £6.8m at 0.3p a share, after expenses. This was required for working capital and product development. That should provide the required cash for the business until at least the third quarter of 2023. Singer forecasts net debt of £2.2m by the end of March 2024. The Taiwan subsidiary is being sold, and a strategic investor is being sought.
pharmaboy3
Chat Pages: 218  217  216  215  214  213  212  211  210  209  208  207  Older

Your Recent History

Delayed Upgrade Clock